Developing Sustainable Business Models for Emerging Markets and Developing Countries – The case of Novo Nordisk (and Roche) engaging in sustainable business in the pharmaceutical industry in EMDCs.
Abstract:
Type:
Private (National)
Bevillingsgiver:
Novo Nordisk AS
Institut:
Department of Management, Society and Communication
Samarbejdspartnere:
Danmarks Tekniske Universitet
Status:
Afsluttet
Startdato:
08-09-2022
Slutdato:
31-05-2023
The page was last edited by: Dean's Office of Research